ID   GPC3_RAT                Reviewed;         597 AA.
AC   P13265; Q5U326;
DT   01-JAN-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1990, sequence version 1.
DT   24-JUL-2024, entry version 145.
DE   RecName: Full=Glypican-3;
DE   AltName: Full=Intestinal protein OCI-5;
DE   Contains:
DE     RecName: Full=Glypican-3 alpha subunit {ECO:0000250|UniProtKB:P51654};
DE   Contains:
DE     RecName: Full=Glypican-3 beta subunit {ECO:0000250|UniProtKB:P51654};
DE   Flags: Precursor;
GN   Name=Gpc3;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND DEVELOPMENTAL STAGE.
RX   PubMed=3185547; DOI=10.1128/mcb.8.10.4243-4249.1988;
RA   Filmus J., Church J.G., Buick R.N.;
RT   "Isolation of a cDNA corresponding to a developmentally regulated
RT   transcript in rat intestine.";
RL   Mol. Cell. Biol. 8:4243-4249(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   SUBCELLULAR LOCATION.
RX   PubMed=7487896; DOI=10.1042/bj3110561;
RA   Filmus J., Shi W., Wong Z.M., Wong M.J.;
RT   "Identification of a new membrane-bound heparan sulphate proteoglycan.";
RL   Biochem. J. 311:561-565(1995).
RN   [4]
RP   INTERACTION WITH FGF2.
RX   PubMed=9065409; DOI=10.1074/jbc.272.12.7574;
RA   Song H.H., Shi W., Filmus J.;
RT   "OCI-5/rat glypican-3 binds to fibroblast growth factor-2 but not to
RT   insulin-like growth factor-2.";
RL   J. Biol. Chem. 272:7574-7577(1997).
CC   -!- FUNCTION: Cell surface proteoglycan (By similarity). Negatively
CC       regulates the hedgehog signaling pathway when attached via the GPI-
CC       anchor to the cell surface by competing with the hedgehog receptor PTC1
CC       for binding to hedgehog proteins (By similarity). Binding to the
CC       hedgehog protein SHH triggers internalization of the complex by
CC       endocytosis and its subsequent lysosomal degradation (By similarity).
CC       Positively regulates the canonical Wnt signaling pathway by binding to
CC       the Wnt receptor Frizzled and stimulating the binding of the Frizzled
CC       receptor to Wnt ligands (By similarity). Positively regulates the non-
CC       canonical Wnt signaling pathway (By similarity). Binds to CD81 which
CC       decreases the availability of free CD81 for binding to the
CC       transcriptional repressor HHEX, resulting in nuclear translocation of
CC       HHEX and transcriptional repression (By similarity). Inhibits the
CC       dipeptidyl peptidase activity of DPP4 (By similarity). Plays a role in
CC       limb patterning and skeletal development by controlling the cellular
CC       response to BMP4 (By similarity). Modulates the effects of growth
CC       factors BMP2, BMP7 and FGF7 on renal branching morphogenesis (By
CC       similarity). Required for coronary vascular development (By
CC       similarity). Plays a role in regulating cell movements during
CC       gastrulation (By similarity). {ECO:0000250|UniProtKB:P51654,
CC       ECO:0000250|UniProtKB:Q6V9Y8, ECO:0000250|UniProtKB:Q8CFZ4}.
CC   -!- SUBUNIT: Heterodimer; disulfide-linked (By similarity). Cleavage by a
CC       furin-like convertase results in production of alpha and beta chains
CC       which form a disulfide-linked heterodimer (By similarity). Interacts
CC       with DPP4 (By similarity). Interacts with FGF2 (PubMed:9065409).
CC       Interacts with WNT5A (By similarity). Also interacts with WNT3A and
CC       WNT7B (By similarity). Interacts with hedgehog protein SHH; the heparan
CC       sulfate chains are not required for the interaction (By similarity).
CC       Also interacts with hedgehog protein IHH (By similarity). Interacts
CC       with CD81 (By similarity). Interacts with Wnt receptors FZD4, FZD7 and
CC       FZD8; the heparan sulfate chains are required for the interaction (By
CC       similarity). {ECO:0000250|UniProtKB:P51654,
CC       ECO:0000250|UniProtKB:Q8CFZ4, ECO:0000269|PubMed:9065409}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:7487896};
CC       Lipid-anchor, GPI-anchor {ECO:0000269|PubMed:7487896}; Extracellular
CC       side {ECO:0000269|PubMed:7487896}.
CC   -!- DEVELOPMENTAL STAGE: In the intestine, expression decreases gradually
CC       from 20 dpc and finally becomes undetectable after weaning around 24
CC       days after birth. {ECO:0000269|PubMed:3185547}.
CC   -!- PTM: O-glycosylated; contains heparan sulfate and/or chondroitin
CC       sulfate. {ECO:0000250|UniProtKB:P51654}.
CC   -!- PTM: Cleaved intracellularly by a furin-like convertase to generate 2
CC       subunits, alpha and beta, which remain associated through disulfide
CC       bonds and are associated with the cell surface via the GPI-anchor. This
CC       processing is essential for its role in inhibition of hedgehog
CC       signaling. A second proteolytic event may result in cleavage of the
CC       protein on the cell surface, separating it from the GPI-anchor and
CC       leading to its shedding from the cell surface.
CC       {ECO:0000250|UniProtKB:P51654}.
CC   -!- SIMILARITY: Belongs to the glypican family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M22400; AAA41735.1; -; mRNA.
DR   EMBL; BC085756; AAH85756.1; -; mRNA.
DR   PIR; A30814; A30814.
DR   RefSeq; NP_036906.1; NM_012774.1.
DR   AlphaFoldDB; P13265; -.
DR   SMR; P13265; -.
DR   BioGRID; 247276; 2.
DR   STRING; 10116.ENSRNOP00000075712; -.
DR   GlyCosmos; P13265; 5 sites, No reported glycans.
DR   GlyGen; P13265; 5 sites.
DR   PhosphoSitePlus; P13265; -.
DR   PaxDb; 10116-ENSRNOP00000043344; -.
DR   GeneID; 25236; -.
DR   KEGG; rno:25236; -.
DR   UCSC; RGD:2725; rat.
DR   AGR; RGD:2725; -.
DR   CTD; 2719; -.
DR   RGD; 2725; Gpc3.
DR   eggNOG; KOG3821; Eukaryota.
DR   InParanoid; P13265; -.
DR   OrthoDB; 2939408at2759; -.
DR   PhylomeDB; P13265; -.
DR   Reactome; R-RNO-1971475; A tetrasaccharide linker sequence is required for GAG synthesis.
DR   Reactome; R-RNO-2022928; HS-GAG biosynthesis.
DR   Reactome; R-RNO-2024096; HS-GAG degradation.
DR   Reactome; R-RNO-381426; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs).
DR   Reactome; R-RNO-8957275; Post-translational protein phosphorylation.
DR   Reactome; R-RNO-975634; Retinoid metabolism and transport.
DR   PRO; PR:P13265; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0009986; C:cell surface; IBA:GO_Central.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; IEA:InterPro.
DR   GO; GO:0005764; C:lysosome; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0098552; C:side of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0060422; F:peptidyl-dipeptidase inhibitor activity; ISS:UniProtKB.
DR   GO; GO:0009887; P:animal organ morphogenesis; ISO:RGD.
DR   GO; GO:0009948; P:anterior/posterior axis specification; ISO:RGD.
DR   GO; GO:0010171; P:body morphogenesis; ISO:RGD.
DR   GO; GO:0030282; P:bone mineralization; ISO:RGD.
DR   GO; GO:0001658; P:branching involved in ureteric bud morphogenesis; ISO:RGD.
DR   GO; GO:0060070; P:canonical Wnt signaling pathway; ISO:RGD.
DR   GO; GO:0016477; P:cell migration; IBA:GO_Central.
DR   GO; GO:0042074; P:cell migration involved in gastrulation; ISS:UniProtKB.
DR   GO; GO:0072111; P:cell proliferation involved in kidney development; ISS:UniProtKB.
DR   GO; GO:0072203; P:cell proliferation involved in metanephros development; ISO:RGD.
DR   GO; GO:0060976; P:coronary vasculature development; ISS:UniProtKB.
DR   GO; GO:0035116; P:embryonic hindlimb morphogenesis; ISO:RGD.
DR   GO; GO:0050673; P:epithelial cell proliferation; ISO:RGD.
DR   GO; GO:0001822; P:kidney development; ISO:RGD.
DR   GO; GO:0030324; P:lung development; ISO:RGD.
DR   GO; GO:0072138; P:mesenchymal cell proliferation involved in ureteric bud development; ISO:RGD.
DR   GO; GO:0072180; P:mesonephric duct morphogenesis; ISS:UniProtKB.
DR   GO; GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IDA:MGI.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0050680; P:negative regulation of epithelial cell proliferation; ISO:RGD.
DR   GO; GO:0045926; P:negative regulation of growth; ISO:RGD.
DR   GO; GO:0045879; P:negative regulation of smoothened signaling pathway; ISS:UniProtKB.
DR   GO; GO:0030316; P:osteoclast differentiation; ISO:RGD.
DR   GO; GO:0030513; P:positive regulation of BMP signaling pathway; ISO:RGD.
DR   GO; GO:0090263; P:positive regulation of canonical Wnt signaling pathway; ISS:UniProtKB.
DR   GO; GO:0045807; P:positive regulation of endocytosis; ISS:UniProtKB.
DR   GO; GO:0046326; P:positive regulation of glucose import; ISO:RGD.
DR   GO; GO:0045732; P:positive regulation of protein catabolic process; ISS:UniProtKB.
DR   GO; GO:0045880; P:positive regulation of smoothened signaling pathway; ISO:RGD.
DR   GO; GO:2000096; P:positive regulation of Wnt signaling pathway, planar cell polarity pathway; IDA:MGI.
DR   GO; GO:0060828; P:regulation of canonical Wnt signaling pathway; ISO:RGD.
DR   GO; GO:0040008; P:regulation of growth; ISO:RGD.
DR   GO; GO:2000050; P:regulation of non-canonical Wnt signaling pathway; ISO:RGD.
DR   GO; GO:1905475; P:regulation of protein localization to membrane; IBA:GO_Central.
DR   GO; GO:0009617; P:response to bacterium; ISO:RGD.
DR   GO; GO:0007224; P:smoothened signaling pathway; ISO:RGD.
DR   GO; GO:0060071; P:Wnt signaling pathway, planar cell polarity pathway; ISO:RGD.
DR   InterPro; IPR001863; Glypican.
DR   InterPro; IPR019803; Glypican_CS.
DR   PANTHER; PTHR10822; GLYPICAN; 1.
DR   PANTHER; PTHR10822:SF4; GLYPICAN-3; 1.
DR   Pfam; PF01153; Glypican; 1.
DR   PROSITE; PS01207; GLYPICAN; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Disulfide bond; Glycoprotein; GPI-anchor; Heparan sulfate;
KW   Lipoprotein; Membrane; Phosphoprotein; Protease inhibitor; Proteoglycan;
KW   Pyrrolidone carboxylic acid; Reference proteome; Signal.
FT   SIGNAL          1..24
FT                   /evidence="ECO:0000255"
FT   CHAIN           25..357
FT                   /note="Glypican-3 alpha subunit"
FT                   /evidence="ECO:0000250|UniProtKB:P51654"
FT                   /id="PRO_0000445416"
FT   CHAIN           358..?
FT                   /note="Glypican-3 beta subunit"
FT                   /evidence="ECO:0000250|UniProtKB:P51654"
FT                   /id="PRO_0000445417"
FT   PROPEP          ?..597
FT                   /note="Removed in mature form"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_0000012314"
FT   REGION          533..553
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         25
FT                   /note="Pyrrolidone carboxylic acid"
FT                   /evidence="ECO:0000250|UniProtKB:P51654"
FT   MOD_RES         351
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P51654"
FT   CARBOHYD        123
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        240
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        417
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        494
FT                   /note="O-linked (Xyl...) (glycosaminoglycan) serine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        508
FT                   /note="O-linked (Xyl...) (glycosaminoglycan) serine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        34..71
FT                   /evidence="ECO:0000250|UniProtKB:P35052"
FT   DISULFID        64..261
FT                   /evidence="ECO:0000250|UniProtKB:P35052"
FT   DISULFID        72..264
FT                   /evidence="ECO:0000250|UniProtKB:P35052"
FT   DISULFID        196..348
FT                   /evidence="ECO:0000250|UniProtKB:P35052"
FT   DISULFID        251..284
FT                   /evidence="ECO:0000250|UniProtKB:P35052"
FT   DISULFID        273..421
FT                   /note="Interchain (between alpha and beta chains)"
FT                   /evidence="ECO:0000250|UniProtKB:P35052"
FT   DISULFID        277..409
FT                   /note="Interchain (between alpha and beta chains)"
FT                   /evidence="ECO:0000250|UniProtKB:P35052"
FT   CONFLICT        553
FT                   /note="S -> N (in Ref. 2; AAH85756)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        583..584
FT                   /note="CP -> VSQ (in Ref. 2; AAH85756)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   597 AA;  67049 MW;  C556AD4127685687 CRC64;
     MAGTVRTACL LVAMLLGLGC LGQAQPPPPP DATCHQVRSF FQRLQPGLKW VPETPVPGSD
     LQVCLPKGPT CCSRKMEEKY QLTARLNMEQ LLQSASMELK FLIIQNAAVF QEAFEIVVRH
     AKNYTNAMFK NNYPSLTPQA FEFVGEFFTD VSLYILGSDI NVDDMVNELF DSLFPVIYTQ
     MMNPGLPESV LDINECLRGA RRDLKVFGSF PKLIMTQVSK SLQVTRIFLQ ALNLGIEVIN
     TTDHLKFSKD CGRMLTRMWY CSYCQGLMMV KPCGGYCNVV MQGCMAGVVE IDKYWREYIL
     SLEELVNGMY RIYDMENVLL GLFSTIHDSI QYVQKNGGKL TTTIGKLCAH SQQRQYRSAY
     YPEDLFIDKK VLKVARVEHE ETLSSRRREL IQKLKSFISF YSALPGYICS HSPVAENDTL
     CWNGQELVER YSQKAARNGM KNQFNLHELK MKGPEPVVSQ IIDKLKHINQ LLRTMSVPKG
     KVVDKSLDEE GLESGDCGDD EDECIGSSGD GMMKVKNQLR FLAELAYDLD VDDAPGNKQH
     GNQKDNEITT SHSVGNMPSP LKILISVAIY VACFFSWCTD LPCPCLCCPA APCGPPT
//
